Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome
The overall objectives are to explore the safety and efficacy of Reverse Transcriptase Inhibitors Tenofovir (TDF)/ Emtricitabine (FTC) administered in AGS affected children 2 to 18 years of age.
100 Clinical Results associated with Emerson Resources, Inc.
0 Patents (Medical) associated with Emerson Resources, Inc.
100 Deals associated with Emerson Resources, Inc.
100 Translational Medicine associated with Emerson Resources, Inc.